SLU7 Antibody - #DF4330
| 製品: | SLU7 Antibody |
| カタログ: | DF4330 |
| タンパク質の説明: | Rabbit polyclonal antibody to SLU7 |
| アプリケーション: | WB IF/ICC |
| 反応性: | Human, Mouse, Rat |
| 予測: | Pig, Bovine, Horse, Sheep, Rabbit, Dog, Chicken, Xenopus |
| 分子量: | 65 KD; 68kD(Calculated). |
| ユニプロット: | O95391 |
| RRID: | AB_2836698 |
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# DF4330, RRID:AB_2836698.
折りたたみ／展開
9G8; hSlu7; MGC9280; Pre mRNA splicing factor SLU7; Pre-mRNA-splicing factor slu7; SLU 7; slu7; SLU7 splicing factor homolog (S. cerevisiae); SLU7 splicing factor homolog; SLU7_HUMAN; splicing factor; Step II splicing factor SLU7; Zinc knuckle motif containing;
免疫原
- O95391 SLU7_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MSATVVDAVNAAPLSGSKEMSLEEPKKMTREDWRKKKELEEQRKLGNAPAEVDEEGKDINPHIPQYISSVPWYIDPSKRPTLKHQRPQPEKQKQFSSSGEWYKRGVKENSIITKYRKGACENCGAMTHKKKDCFERPRRVGAKFTGTNIAPDEHVQPQLMFDYDGKRDRWNGYNPEEHMKIVEEYAKVDLAKRTLKAQKLQEELASGKLVEQANSPKHQWGEEEPNSQMEKDHNSEDEDEDKYADDIDMPGQNFDSKRRITVRNLRIREDIAKYLRNLDPNSAYYDPKTRAMRENPYANAGKNPDEVSYAGDNFVRYTGDTISMAQTQLFAWEAYDKGSEVHLQADPTKLELLYKSFKVKKEDFKEQQKESILEKYGGQEHLDAPPAELLLAQTEDYVEYSRHGTVIKGQERAVACSKYEEDVKIHNHTHIWGSYWKEGRWGYKCCHSFFKYSYCTGEAGKEIVNSEECIINEITGEESVKKPQTLMELHQEKLKEEKKKKKKKKKKHRKSSSDSDDEEKKHEKLKKALNAEEARLLHVKETMQIDERKRPYNSMYETREPTEEEMEAYRMKRQRPDDPMASFLGQ
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - O95391 基板として
| Site | PTM Type | Enzyme | Source |
|---|---|---|---|
| S2 | Acetylation | Uniprot | |
| S15 | Phosphorylation | Uniprot | |
| K44 | Sumoylation | Uniprot | |
| K78 | Ubiquitination | Uniprot | |
| K83 | Ubiquitination | Uniprot | |
| K93 | Ubiquitination | Uniprot | |
| Y102 | Phosphorylation | Uniprot | |
| K103 | Ubiquitination | Uniprot | |
| K107 | Ubiquitination | Uniprot | |
| S110 | Phosphorylation | Uniprot | |
| K131 | Ubiquitination | Uniprot | |
| Y163 | Phosphorylation | Uniprot | |
| K166 | Ubiquitination | Uniprot | |
| K187 | Sumoylation | Uniprot | |
| K187 | Ubiquitination | Uniprot | |
| K199 | Sumoylation | Uniprot | |
| K199 | Ubiquitination | Uniprot | |
| K208 | Ubiquitination | Uniprot | |
| S215 | Phosphorylation | Uniprot | |
| S227 | Phosphorylation | Uniprot | |
| S235 | Phosphorylation | Uniprot | |
| Y243 | Phosphorylation | Uniprot | |
| S256 | Phosphorylation | Uniprot | |
| K257 | Sumoylation | Uniprot | |
| K257 | Ubiquitination | Uniprot | |
| T261 | Phosphorylation | Uniprot | |
| K273 | Ubiquitination | Uniprot | |
| Y284 | Phosphorylation | Uniprot | |
| K288 | Ubiquitination | Uniprot | |
| Y297 | Phosphorylation | Uniprot | |
| K302 | Acetylation | Uniprot | |
| K302 | Ubiquitination | Uniprot | |
| S308 | Phosphorylation | Uniprot | |
| K349 | Ubiquitination | Uniprot | |
| Y354 | Phosphorylation | Uniprot | |
| K355 | Ubiquitination | Uniprot | |
| K369 | Ubiquitination | Uniprot | |
| K375 | Ubiquitination | Uniprot | |
| Y397 | Phosphorylation | Uniprot | |
| Y400 | Phosphorylation | Uniprot | |
| K408 | Ubiquitination | Uniprot | |
| K418 | Sumoylation | Uniprot | |
| S466 | Phosphorylation | Uniprot | |
| K482 | Sumoylation | Uniprot | |
| K482 | Ubiquitination | Uniprot | |
| K493 | Ubiquitination | Uniprot | |
| S513 | Phosphorylation | Uniprot | |
| S515 | Phosphorylation | Uniprot | |
| K540 | Acetylation | Uniprot | |
| K540 | Ubiquitination | Uniprot | |
| S554 | Phosphorylation | Uniprot | |
| S582 | Phosphorylation | Uniprot |
研究背景
Required for pre-mRNA splicing as component of the spliceosome. Participates in the second catalytic step of pre-mRNA splicing, when the free hydroxyl group of exon I attacks the 3'-splice site to generate spliced mRNA and the excised lariat intron. Required for holding exon 1 properly in the spliceosome and for correct AG identification when more than one possible AG exists in 3'-splicing site region. May be involved in the activation of proximal AG. Probably also involved in alternative splicing regulation.
Nucleus. Nucleus speckle. Cytoplasm.
Note: Predominantly nuclear. Shuttling between the nucleus and the cytoplasm is regulated by the CCHC-type zinc finger. Upon UV-C stress stimulus, the nuclear concentration of the protein decreases, affecting alternative splicing. Translocates from the nucleus to the cytoplasm after heat shock cell treatment. Accumulates in cytoplasmic vesicle-like organelles after heat shock treatment, which may represent stress granules.
Component of pre-catalytic, catalytic and post-catalytic spliceosomes. Associates with the spliceosome prior to recognition of the 3'-splice site for step II, probably during catalysis of step I.
The CCHC-type zinc finger is required to retain the protein within the nucleus and prevent its shuttle back to the cytoplasm via the CRM1 pathway.
Belongs to the SLU7 family.
研究領域
· Genetic Information Processing > Transcription > Spliceosome.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.